These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Emerging Necessity of Myeloid Mutational Analysis in Early T-cell Precursor Acute Lymphoblastic Leukemia/Lymphoma (ETP-ALL). Tariq H; Shetty S Turk J Haematol; 2023 Aug; 40(3):227-229. PubMed ID: 37431282 [No Abstract] [Full Text] [Related]
30. STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia. Tremblay CS; Saw J; Boyle JA; Haigh K; Litalien V; McCalmont H; Evans K; Lock RB; Jane SM; Haigh JJ; Curtis DJ Blood; 2023 Jul; 142(3):274-289. PubMed ID: 36989489 [TBL] [Abstract][Full Text] [Related]
31. ETP-ALL with aberrant B marker expression: Case series and a brief review of literature. Garg S; Gupta SK; Bakhshi S; Mallick S; Kumar L Int J Lab Hematol; 2019 Apr; 41(2):e32-e37. PubMed ID: 30407727 [No Abstract] [Full Text] [Related]
32. [A clinical study of allogeneic hematopoietic stem cell transplantation in 23 patients with early T-cell precursor acute lymphoblastic leukemia]. Zhu YX; Zhu MQ; Dai HP; Liu SN; Yin J; Li Z; Cui QY; Zhu XM; Wu DP; Tang XW Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1021-1025. PubMed ID: 32023734 [No Abstract] [Full Text] [Related]
33. Childhood Early T Cell Precursor Acute Lymphoblastic Leukaemia with t(12;17) (p13;q21) Translocation - A Rare Entity or Part of ETP/Myeloid Mixed Phenotype Acute Leukaemia. Krishnan Y; S G; Joy A; S SP; S RJ; S S Gulf J Oncolog; 2022 Sep; 1(40):78-82. PubMed ID: 36448075 [TBL] [Abstract][Full Text] [Related]
34. [Identification of Differentially Expressed Gene Core Genes in Early T-Cell Precursor Acute Lymphoblastic Leukemia and Its Regulatory Network Analysis]. Lun YZ; Sun J; Yu ZG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):673-684. PubMed ID: 31204916 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia. Kühnl A; Gökbuget N; Kaiser M; Schlee C; Stroux A; Burmeister T; Mochmann LH; Hoelzer D; Hofmann WK; Thiel E; Baldus CD Blood; 2011 Dec; 118(24):6362-7. PubMed ID: 22010100 [TBL] [Abstract][Full Text] [Related]
36. Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in Carr T; McGregor S; Dias S; Verykokakis M; Le Beau MM; Xue HH; Sigvardsson M; Bartom ET; Kee BL Front Immunol; 2022; 13():845488. PubMed ID: 35371057 [TBL] [Abstract][Full Text] [Related]
37. Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia. Ashry MSE; Radwan E; Abdellateif MS; Arafah O; Hassan NM J Egypt Natl Canc Inst; 2023 Jun; 35(1):17. PubMed ID: 37303010 [TBL] [Abstract][Full Text] [Related]
38. CRLF2 overexpression defines an immature-like subgroup which is rescued through restoration of the PRC2 function in T-cell precursor acute lymphoblastic leukemia. Maciel ALT; Wolch K; Emerenciano M; Mansur MB Genes Chromosomes Cancer; 2022 Jul; 61(7):437-442. PubMed ID: 35253299 [TBL] [Abstract][Full Text] [Related]